[Pharmwaste] Pharmaceutical Waste

Ann Heil aheil@lacsd.org
Wed, 19 Jan 2005 07:33:12 -0800


This is a multi-part message in MIME format.

------=_NextPart_000_0007_01C4FDF9.22B9C320
Content-Type: text/plain;
	charset="US-ASCII"
Content-Transfer-Encoding: 7bit

What if we had a handy way to render controlled substances nonrecoverable?
Let's speculate that we had some sort of small kit, containing a bitter
liquid into which liquid drugs could be poured, and a quick setting cement
into which solid drugs could be placed. Could we get around controlled
substance regs by having the person dropping them off apply this kit prior
to dropping them off? The group that is collecting the pharmaceuticals would
then not be subject to controlled substances regs, because the controlled
substances would have already been rendered nonrecoverable.
 
Ann Heil
LACSD

-----Original Message-----
From: pharmwaste-admin@lists.dep.state.fl.us
[mailto:pharmwaste-admin@lists.dep.state.fl.us]On Behalf Of Charlotte A.
Smith
Sent: Tuesday, January 18, 2005 4:49 PM
To: Chapman, Alice; Bill Lewry; pharmwaste@lists.dep.state.fl.us
Subject: RE: [Pharmwaste] Pharmaceutical Waste


Thanks, Alice, that issue about the licensee being a person is correct when
it has to do with dispensed controlled substances. That what makes take back
to problematic. 
 
 

Charlotte A. Smith, R. Ph., M.S., HEM
President
PharmEcology Associates, LLC
200 S. Executive Drive, Suite 101
Brookfield, WI 53005
262-814-2635
Fax 414-479-9941 

H2E Champion for Change Award

-----Original Message-----
From: Chapman, Alice [mailto:Alice.Chapman@METROKC.GOV] 
Sent: Tuesday, January 18, 2005 6:27 PM
To: Bill Lewry; pharmwaste@lists.dep.state.fl.us
Subject: RE: [Pharmwaste] Pharmaceutical Waste


Just to clarify a side issue mentioned in your question...
 
Neither the FDA nor the DEA approves or permits incinerators for disposal of
drugs.  The DEA regulations require that controlled substances be destroyed
"beyond reclamation".  We're accustomed in the world of hazardous waste to
having particular sites permitted and approved by EPA.  The DEA looks at it
differently.  As long as the drugs are in the custody of an approved
"licensee" (often a person), and "destroyed beyond reclamation",
everything's fine.  Incineration is a handy way of making drugs
non-reclamable!  Every incinerator I've talked to (I called as many as I
could find in the US a couple of years ago) has burned controlled
substances.  Usually the licensee witnesses the drugs as they go into the
system.  The drugs can't sit around in storage on-site before burning, that
would require facility changes to meet security requirements.  
 
The loop you're attributing to FDA, is actually managed by DEA and state
Boards of Pharmacy.
 
Pharmaceuticals can be found in every category of hazardous waste.  Your
proposal would work for many, but drugs packaged as inhalers (compressed
gases) or as injections (dose of drug in syringe attached to needle & ready
to go) would need to be handled differently.  
 
The major drawback I see in your proposal is that disposal costs are paid
for by local governments, and the relatively low collection rate of
hazardous stuff out there that actually makes it's way to government-run
collection sites.  I'd like to see what can happen when there are as many
collection points for drugs as there are pharmacies.
 
:)  ac

Alice Chapman, PE
Local Hazardous Waste Management Program in King County
130 Nickerson St, #100
Seattle, WA  98109
http://www.govlink.org/hazwaste/ <http://www.govlink.org/hazwaste/> 
 
206-263-3058 phone
206-263-3070 fax
 
 
  _____  

From: Bill Lewry [mailto:Bill_Lewry@kcmo.org] 
Sent: Saturday, January 15, 2005 12:53 PM
To: pharmwaste@lists.dep.state.fl.us
Subject: [Pharmwaste] Pharmaceutical Waste



Dear Listserve:

I would appreciate if someone could provide answer to the following
question.

Simply out of curiosity, I understand the (potential / possible) need to
create a system to deal with this issue, but unlike latex paint, electronics
and carpet, amongst others, it would appear to this uninitiated person that
there is little reclaimable asset to be gained from spent / out of date
pharmaceuticals.

Allowing that there is little benefit, then we have the issue of these not
falling into inappropriate hands. At least in the narcotics area.

Pharmaceuticals once issued to the end user are "out of the loop" of the FDA
and would then at end of life become "HHW", and it appears should then be
treated as any other HHW.

It would appear that these items would simply be best placed amongst other
"toxics", drummed without external indicative labelling (Eg. NOS, Toxic, 6
(6.1)) and shipped for incineration. They would not then require to go to an
FDA approved incinerator.

An alternative would be to place in an A fuel drum (all parties in
agreement) and ship in that fashion.

For the amounts and quantities involved in most programs, this would seem
the easy solution, for programs specifically chasing these wastestreams as a
revenue source, they could arrange contracts as appropriate under auspices
of the FDA if they themselves saw a need to regulate material which was
regulatorily in the vast majority of cases "de-regulated" by age or
condition.

I look forward to the discussion thread this question line may provoke.

Sincerely.

Bill Lewry / KCMO.


------=_NextPart_000_0007_01C4FDF9.22B9C320
Content-Type: application/ms-tnef;
	name="winmail.dat"
Content-Transfer-Encoding: base64
Content-Disposition: attachment;
	filename="winmail.dat"

eJ8+Ig4PAQaQCAAEAAAAAAABAAEAAQeQBgAIAAAA5AQAAAAAAADoAAEIgAcAGAAAAElQTS5NaWNy
b3NvZnQgTWFpbC5Ob3RlADEIAQ2ABAACAAAAAgACAAEGgAMADgAAANUHAQATAAcAIQAAAAMAGwEB
A5AGAJwiAAAnAAAACwACAAEAAAALACMAAAAAAAMAJgAAAAAACwApAAAAAAADAC4AAAAAAAMANgAA
AAAAHgBwAAEAAAAiAAAAW1BoYXJtd2FzdGVdIFBoYXJtYWNldXRpY2FsIFdhc3RlAAAAAgFxAAEA
AAAWAAAAAcT+PC+qAD0d6JArSdmw5R4G3i0XhQAAAgEdDAEAAAAVAAAAU01UUDpBSEVJTEBMQUNT
RC5PUkcAAAAACwABDgAAAABAAAYOAB5AKDz+xAECAQoOAQAAABgAAAAAAAAADXLFVbdB0xGv5QAA
9j3ScMKAAAADABQOAQAAAAsAHw4BAAAAAgEJEAEAAAB1HgAAcR4AAN9zAABMWkZ1kgYbbAMACgBy
Y3BnMTI1gjIDQ2h0bWwxAzA/AQMB9wqAAqQD4wIAY2jBCsBzZXQwIAcTAoD/EAMAUARWCFUHshHV
DlEDAd0Q1zIGAAbDEdUzBEYQ2VkS72Y0EG8RezUDxlR8YWgDcQKAEeMI7wn3O3scHw4wNR0/HkMR
4QxgY2cAUAsJAWQzNhFgC6U0siAQAipcDrIBkGciEAAzIDwhRE9DVABZUEUgSFRNTAAgUFVCTElD
IIAiLS8vVzNDJNBIRFREI+Q0LhFgVHJyAHJ0aQIgB0Ak0EX4TiI+EeMihyMwCqMnPGwxOSNAI/N4
DtAAgDoobyA9KCQiCHBuOokE8GhlAMBzLW0N4KkDYHNvAYAtBaBtKkB7ASAN4GUshScfIiApkEVE
QUQnLTE3NyNAVHBJVExFJy0iEA7wTZUHkHMi8GUojTg1I0C+LzAvKTIoLzRvKPY2DvDAPE1FVEEg
BaACMLEJ8HQ9IgXgI/M2JeAwMC4yOTjyDkAzIiYgJqAHgD1HJvBFUvBBVE9SJy0xcTMwLq8XIvE1
/yLhNRFgPEJPHERZJy0hkT1fZzk2cSNARElWJyAikwAhIM8AAEHVEWAiaTY0Qb9CwgkonDQ4I0BG
T05UfCBmANA6AAcTN8EbsT2uIzjwOPABICAAkHo6AO4yQasYMAMwYxPwA7IB0BcDMESfIsM4LnFT
UEEOTjfAC2AEED0wMTXqMQ4gOUygLSlgTJAB0OwwNUGvQrNXGPAFQDrcQz/1BpAgd2UgGPBkRCBh
UQFuZHlQ0GH9UbB0KlAcIFGQEzE30gNgjGxsCYBIEHVicwGQdm4s0AQgbgIgHCAFoHaXBJABoFMg
P0reJm5TgMZwAoBN11wnYQFAQnfrT19AE0wRQCcEIFYwBZD+dQtgOABSAE8iUOUsAAeAe1rxACAg
LBBIEADAUxAgumsmYCw3wwtxC4BnUUEOYiZgOAAFwGxpcXU+aVEwV/9QcwIwKlB3aIUN4GhdtmRy
dWcEINcFoFngUTBiUPBwCGEJgM9cYFGBUUFd4WNrSBARQN8mcF0BLNAHgAIwIF+JXj8/QCIsAF3A
YI8LUSzQZC7/FxJhMVDhMfAFQArACGBiIe9Sv1PBUjFg0WJRsGR/QCL9GPB2XPJaQGFxBJAsAAOg
0WCgb3BwbCVtW5FCMPphbUBsUfFf4AQgXDFhgG8FEAWxUhFtHz9qn0ATVPdscQnACGBwWjRusRuR
UyCeY2MDbGMY8QDBZXUmcPZjB0AEIHdhE2xhA6BUEPcFQGFhU2Fqc5FSAnDvQCK/aN9Tw2oiXGBh
YHTwdRkg/2xTeG9Tw3VEa/FQ8AdAHCD/USBqj0AEYWB1wVJEUzFUHP4uQGwU8DMwS+JNuU3HRQ76
NUFBL0ZCgf9CvgHATcfvCqKCqAqAKJwwLnElMEGL/4KvP39Aj0Gfhc9Dv4rvRd//Ru9H/0kPSh9L
LwqjTD9NT/+Qn4Dvie+bT4QfnV9VH1Yv/1c5hi+HP4hPiV+gT4t/jI//jZ+jf4+/qJ+R35Lvk/+V
D5+WH5cvTA+Zn6wtQW4DoPN9f6oySGUDEJufnK+0T/+ez7xvo8+k36Xvpv+/b6kf/6ovqz+sT61f
rm+vf7CPsZ9/sq+zv7TPl/+2n7evySVM8EFDU0S6/7wP0M++L//Xv8BPwV/Cb8N/2r/Fn8avB8ez
JGAjgEtRVU9UeSPQZGnOECLQBcBTkHkDUyA4QUFSR0lOLQhSSUcj8DogMHB+eC1hopgKsRAC5EEK
sVz+cRwA5EFgAeBf4W8ielfBN+Ivx+PTBU90wBuwb2s/MaW6sFEgEzHkBgdAaWf+buQwAXHUm+dP
57DoOcmf+9Tv8FBpIXLLv8zJGsTpxK9X0M6/GgLQXy350k8FEP5nC4DNoTGl+dMonDcwPpHnOqGi
mF3AbmUKgehftWeqQtSbYug5RgNhOtZP/i//iuBJuV/p77Wi60F0Q59R0FOQ+xBRICuwbkBdwMlT
kHMuDyBwLlOROADwLmZsLnpgBA8FHwYl7lt0gBRAUhA6Bp8HrwiyLl3+f/+P8bdPbPBCZfUY8GzI
wE/IwAF/Ao/x1X5DGPEbsF1xCP8KDwYlQf1ncFMrsFpA+3/8j/2fDq97D7/x5FM4EQFvEv8Dh1Ra
dVPgZFHgXGBKJjB1P9LgfVAy8Fxg1FIlwDo0+SlwUE0YLxk/Gk8bXxxv/fHkVAvgHi8fPwOfFb8F
vNUUgXB0gG5cYEFdwM1A3jsRQAuw8YBZQHchoC6w/ytfLG8GPg0PCKMi3yPvJP9/Jg8nHx11dnQo
rym/KsdS0kXlsFtQDBddL48wn/8xpT0zdJdPAAxiNB81LzY//0HvQv9ED9lvO3/bj9yf3a//3r9J
X+jPPu/q78d/81/yTxdTz/RvtY899KA4Mjf/zJDOQNQPyt/1D8z/zgn3D+/PX9BucjAhYGt58S5j
egD3ctV5EHzRYnxQdsFscS5y/m56cGyAZuBsIvbgbKVzI75yf9FoQD3/UL8GNHd1st9u8XLgczBv
gnbwdxfx7mH/olBkMnyAeu95chewYcF2EPdosHLxdIBreZFQQGzwZi+rZz8xpWJdIGt20nBygP+A
UXSAQQEXsEe/SM9O/9av/3LfSk9LX0xvTX91z0+fbo//Ub9Sz1PfVO9V/1cPod+i7/9233fveP96
D3sffC99P35P/39fgG+Bf4KPg5+Er4W/hs//h9+I74n/iw+MH40vnL2RoFU7MFDTBU1lQEHtMG/+
U/pA7u/meZJ5ke+S95T4b/F7FIgXpmKQUnEwPTAu8WKQTS5Tp1Ftj5yfBjTcSEUiz0W/Rs1QZeBf
EL8IAB3wqp+rr6y9DBJFzdLKZyGwQdNAb2NdgBTw8WIRTExDri+vP0bcWgGzHcBxMEV4ZfBA8XZj
4P5E+jC2wKfPqN8xljnAF/C7Y+CZkDGy77P/RtxCawBB7XBmaWVsZGKQV/BJIDUzWhG6f7uPtQ1Q
NjItOFxwLcGwM8e+r7+/Rs1GYXi3X7hvBTGlNMIBNDc5LTn+OcgwnN3SQQvhw7CTj5Sf+5WqnNw1
OyLKE5dPmFWhH/fMz5bUOzFQyk2cX51vnn//n4+gn6M/pE/Rb8mfW+9c8M9dy9ibYIOV10gy4+AU
gehtcGllUWZd8MWv1C/PLWhkwKZBDFByZHFfcm//mt/Nr86/z8/Q39Hv0v/jLwPVH47IQkxPQ0tR
+FVPVOFQaiBeAOLQ71AFa6B5azA9Ik1BUgBHSU4tUklHSMJUPQAwcHgi2JvywffvMaTh9VJjagDs
T+6v777/8J+PP1r/mS/nD/wf99/477v5/li1T9eAFMC9oE1r8OJz4vBlSGUMsGUgY/D15OE9amAt
CNHyhtf/9Q//9hTbC5D/+0+TEZcQW49clodepSswXRNUYWhvbNCvXw9gEiJAYM4tEPJPtwD+Z0bA
QTED5RDzwn/Dj0bf7zdPOF/FFWsAbTo/O08qx98t3OI/AB8xpAGRW2zQLuAV15A6LmMuLdVATUUA
VFJPS0MuR0/+Vj3dE28UfxWPFp85Ka3xFxiPGZ8qx1RjMHNkYWp5YpBKa8B1HTCx0DEeOLdPHR8e
KFoCIDY6/1lQpyCqjyH/Iw8kHyUvYVZvHyAm/ygPPGZCHvBdoEx0ZXcqcDsq3yvvHjdwPT1HQAYA
a6BsAASAcC7Da6G6EC5mbC4FQC5Pvy9fMG8xfzKPJkVrgGpl8ac0HzUvKQdSRfQwW7EjfzpzIN04
Xx4KsSNdIbaRY/1dkVc6gjwvPT8+T0ofSy//TD/l70OPlh+XL5g//N9Rj//+/0b/AR8CLQV/Bo8H
n1Ifnwm/Cs8/L3VC1tU3MMHwxjVV4N8wLTE5ulAtgu/6/1eP3gkN00G3ABGhDUe/3rsOjw+SRtHg
UxANSgVA7nRwQtbhtwBmsdAOcgSAyiA64HMpoCBtrfHhwYxlZG4Q4eB5b3XiL9tYzx4ocSmhbrIu
csBP7/9Q/1cvQrpjQnRvUm9Tf1SP/1Wfd19Xv3CfWd9a71v/XQ//Xh94D2A/YU9iX2NvZH9lj/9m
n2evaL9pz2rfECty/3QP/3z/di+UD5Ufyz/MTniPeZ//eq97v5c/fd9+73//gQ+CH/+DL4Q/hU+L
D4dviH+Jj4qff59/jL+Nz47fj++Q/6dmTjplugBoBJG1IcVgREHMIG7iEbVyREW10BtQqnAYUHYp
sCDiEXAEkH5tugAFUG+voS8tBk7wY/1O8XI7kN7gBVDiAvKAmUAWbwQQ2xBvzEBkcnV+ZzsQmB+Z
L8yKM+C2RXL4ZWd11vBusgVQwDByQP/ykBwAtSA7kLfvuP8eN96w/ybAGFA24G7xbkC94KCwuqC9
txFiHAAEgDrwGFB5bvH2IsXAb1BubwDAMNbhG3AdbrIivL+9z77cV2Un38FBwc/C3y0GDeBjbMEO
UOtu9LVyd+IQbG8AvDHhgH565VFvYAVQOnNs8uGAdv9O8NfQzDFJMcBh8uG1ELcR/8s/zE85p7eD
O6BvAATQ1VHrtsRvAGJtkEWrkMffyO//vt+2YwOiBVDBkbUQpAHfYPMEkCaxbHnWr9e/2MzSP/vT
Ty0GQQVQA6DQ8QMwtWPfvGOkgMFBzoXN82RtkLwxGwTQ1agiH1LAwGVlIvwgKLwwO6Dj8d6P35/U
Stpzx6ApG6DVciLF+Mave8ewG6Bl1gAqcLUg0OEn/7tBTvHbn9yv3b/mH+cvonP+Sbqmx5FuEW2h
G0DG4G2Q99Ag45MbcGvQ4uIktfAFIHXHFWKk8CHsf+2P2NtFH+ti71/wb7oPuxEgSSc31gBs8KSQ
a27xbQEoSf8DAKSQxNLhsRtxbZEFUP1hz29gzyHsIc5nVVPlv/nv+cO7dXCk8LwixlABQNph+Gdv
Kc9xxaFvcG7ixG/vxXLsb/a/2MxVbkD9kSqA/7VyAD8BTy0G5LbO4LUQTwD/EfC3EeHp4cMqgAPg
bxFtAem1cnN5OpFtBi8HP9jP3+IVCe8K/8PnKjAnbODR0d/icW9g/0TOEbrwZwMh9OD/0dLFsbth
GFEEcdDhKsDBc//O8P7iwPYTnxSvLQawIR7w/7UQKoCm0CowF8DhwW0QboD+ZRZxQhBvcB2SwPVu
ggYf/xD/7n+Sr5O/ri+V3yTPmt//m++c/54PJP+gL6E/ok+jX/+kb6V/po+nn6ivqb+qz6vf/6zv
rf+vD7AfsS+yP7NPO9//I58sj0J/Js9EryBvIX81H/8pPypPK18sb0fvLo8vnzCv/zG/Ms8z3zTv
Nf83D0gvOS//Oj9ZDzxfPW8+fz+PQJ9Br3vZotohcG9CyvLycFZAaX8EYNFQ0PFtAbWx6PDy0mP+
dAlE/iEXscZwGq9RX81Wn9ZBtnPG4cVBGEFCb8+x+7chIhBQBCC3kB1Q241Dj/9PX0WvRr9Xn0u/
TM9N33G//3APUQ9SH1MvVD9VT1ZfV2//WH9Zj1qfW69cv4EPXt9f7/9g/2IPYx9Bv22fbq+Mf3DP
/46vSB9JL0o/cz90T3Vfdm//ke94j3mfeq97v3zPfd9+7/9//4W/gh+DL4Q/hU+aL4dvv4h/iY+K
n4uvohRs9WVmgf/9gewAFjHFsrtgFwXrU/1x/9UwA+D40bwxaK+bv81Wz433IC+TrxIcWc/gm8Dk
MbvU+xnEzvFrsOGbwP4i6PBmcfPiFbOgY2toX7NvzQzsAK/sMAQgn4ADoSir8G3kMPsNUsZwZ9Aw
DVAEAPwxvzP+ah7gx4K/0c/Q5QDPQuIi/RczeasQHgG8j72fzUjVIP8dUA6Q/QPsQAVQAxG2T+qw
7beKJgh5H7Bh44HQgQPi/xnExyLQcrDB8yIFQsPPxN//vrba77aft68ir42vmX+Pz/+Q33Jfld+W
75f/mQ/VP5sv/5w/nU+eX59voH+hj6Kfo6//pL+lz6bfp+/dX6oPqx+sL/+tP65P7B/T39zP1f/X
D/Tv/9Cv0b/Yb9l/2o/bn/cf3b//3s/f3+Dv4f/jD+Qf5S/mP//nT+hf6W/qf+uP7J/tr+6/b+/P
8N9kjLsAasEhu6Bh5HdivBEgSR7Bw6DDEf9lsblpZ2EZc8yvAS/OyPlAv7nDEWBr8GdxZfEZEGnA
kL+6wmtBZWCwMcrBsZFuH9P/u0BrshfAw6AfsAvgZpCxkPtn8WVgdxgPGR++pxFhBPC/wcPKMGwS
snG1SGvwdRIRv7Wgu4AeEWXxF8NnmWvA4PlnUHQntcLKgx9PIF++tn0dCC27sLCgIekSQLIAc+fP
//kfuFxJJ8CQBKAlsDvG4hZCdxfSsIK1QHBw/8+gLzEwESa/J8++tiRUG6L/vzG7Aio6ubBmoBtx
usK7pF+/MTM4MJ8xr762cK+Uaf8rLvNf/y/1f/aPB2/7j/yf//2vPm88vwDfAe8C/wQPBR//Bi8H
PwhPCV8Kbwt/DI9Nv/8Orw+/EM8R3xLv8Y86Tztf/1kvPX9bX/fvLD/6Dz/vQP//Qg9DH16fRT9G
T0dfSG9Jf/9Kj0ufTK9Sb07PT99Q71H/f2bfVB9VL1Y/V09YX27EOv4pX19gb9IrFeBZz1rfZq//
XP+A72H/Yw9kH2Uvg99nT/9oX2lvan9rj2yfba+Ej2/P/3Dfce9y/3QPdR92L3c/eE//eV96b1kP
Nz84T4yRiN+T0v+hr4Tfhe+G/414jp+PpJEf/5Ivkz+uuatrnN+d75i/mc83nE+uZK8dQafQmkAg
Q+cv0bsBu0BQRX9vgH+iL/+3j7ifpB+lL6Y/iC+JP4pP/4tfjG+nL6g/qU+qX6tvrH9/rY+un7+v
sL+xz7LfxahMtRyzSCMnV5XwIrFNHdC9n6BlKbKe78EPIVdQFxCqZxWgbRZySzUgZ7TQ+yQQNTB5
tZ+2r7j/2M/Z3/+677v/vQ++H78vwD/BT8Jf/8NvxH/Fj8afx6/Iv8nPyt+f4O/M/84Pzx/m6DEz
4SAmTrSgLqBycyJhU3T9HbAjloHW39fv2j/1X/Zv/9wv3T/eT99f4G/hf+KP45//5K/lv+bP59/o
7+n/6w/sH5/9f+4/70/wXwN4U2UX4OZ0NIAdsFdBfF99by178jmWUDA582/0f/bPFH//FY/4v/nP
+t/77/z//g//H/8ALwE/Ak8DXwRvBX8GjweffwivHJ8KzwvfDO8on5ToQUWayGg2sGY9IhDAdCBw
Oi8vdzBALmdEb3YhAG5rLpuQZ5IvOZB6d9HSLyIrvOk58Gxk0vJmMuA1INHgCHtIWbVwUkxJTsxL
IC/PMN99fSeRMuDH8pDTYCfhMVx1Ino0f98w7Ru/Fm8tX4LlQSuwEo//E58670AfQS8X3xjvGf8b
D/87/x0vHj8fTyBfIW8ifyOP/ySfJa8mvyfPSD8p7yr/LA//VD8+n0dPWR8QHxEuWu9e3/9Of0Qv
RT9GT2BPSG9Jf0qP/0ufTK9Nv07PUY9Q71H/Uw8/WJ9VL1Y/V09x7pRANi1QMjYzLfIQNXPQcPpo
8rBlWV9ab1+fen97j/9hj2KfY69kv2XPZt9n72j//2oPax9sL20/bk9vX3BvcX//gp9zn3Svdb92
z3fRljDSz/eD/6EHmiB4eI95n3vvmU//ml99337vf/+BD4IfhHqQIYeYdaHPoBBTUEFOPg5/n++g
/4M/hE+FX4ZnM2By/YdAdKjAhv+IBKvhqKGIUfmtgmNokqCIb4l/io+OYSMtv6SCIGNs0dBzPQuU
UBJANfMxMC0xOfwwMXdgd/CRu6cfj7+Qx5Eu52NvbDEAPSO0IfwwZhEgkV+Nn7W/l9+mb/88rz2y
pIS+H1v/XQ9eHZyv/52/ns+lv8E/p9+o76n/qw//rB+tL64/r0+1D7Fvsn+zj/+0n8l/tr+3z7jf
ue+6/9g//70fyO+/P8BP4Q/Cb8N/0X//xZ/Gr8e/4z/kT8rvy//ND//OH88v0D/r7+z/7g/vH+rA
CEhSIPTwYkluZDhleD3WwNysN2BxYyXRAGo3cWRi3eB+IP5f+tL6kYtReGDow/RQ87//9M/13/3t
6p/rr/zv/f//D//v7/D/8g/zH9G/13/T39kvyZCyVGF4QG1h3D/dQnY13e/Uf0Lcq/qBCWdGanIO
cDrhzy8SKgF5IAhCaWwJMExld3JueZR/Ay+Wl1sOgBbAdBRvOhayXxcDQGtjVG1vMPJdDH0x3+FC
flLcqftT+/8RbxJ/CbJTOGVudBQPFR8WJ1NhAHR1cmRheSwg8EphbnUvABdA38Ak8B/XEhdfGG+W
l9cAOjUz+CBQTRvfHO8d/x8PIB/9CZRUGmAh3yLvFjZ4MCcwmm02E0AGsDYwcy74kExwLjYwJIBl
LjbALvx1cylPKl8rbyx/LY8hJeB1YmplYyG/MB8WGPcmLyc/GYdQMdcbsD9DkLHQdXRpY5EhVzIi
M8//NN81798v4D9Dz0HfQu/nH//oL+k//+9F7wIPPY8EL4YM/9dfTu9NP05PT19Qb1F/CnN9VYBQ
SFpYQUOKU0+LKEQKZVhRTDKCZXJ2ZT857EfvSP9HD2BvYX1JIIx3b/pRBpBwcHI5sLOREDJAIGnc
IQ5wZXhRx9tRZaJmAG92afiQBpD4bnN3XxA8j1hPlpcaULX4MGhmcGbbcNuAd/twoGcgcXVlMjBp
eFD+LmJvY39hj20Pbh9vLzcvwzg/IVJpbXBsF0BlkHZ0deDmYGMkoGyQDrB0/yTgOf87DxY2ZWBo
n2mvlqY6dfiBcjMR+IBrUyhw7m8yQCGgkRIvZ5B2oA6w0mIHACkgZxBlfPFrQK5jZhBmUg6ReTIx
bX8Cf/iQkSFr8Gtgeb96z2qoaN8ygGaA1gBsUCTwYnYBfGDdBrBraADV4DJAeGeQGiC7IaAk8GUH
ADnAE9BuQKCvg+B80kCwCDBlhcFhG1D/bBAyMHXga2F8oCTwgR+CL/+WpnbAZXhegmszg9F8YPtw
/3bAZkJngXyRZwBrUSSAa1KvZhCD8YUQdsB0BwAgZhH/1eB1kPhQjuGIf4mPlqbV8WuHMH8CYmgA
Z4WRfuFm/xPRDqCHICGgffF19STAZmH/McNAVzKwb99w73H/lm+Xf/2YiUFrxo/fkO+DOI3vaAD7
kwBnEGZ2wCTwa2GNoGhQ/iAx0F8wa1OEA3Yia2FfAP9+sH1wDeEW0JyPnZ+KWyGg92tA+3Bl4m9m
AGZDMdD4gP8ysJwgdhAHADIhpuFrU6cA/wjQfXCGcqQPpR+R939Rli//mj+YT6z/rg+vGkAMg+Bn
AP8OEIP0fvNrYiGQZcAzoGhh+ayBICJ19Wtiqe+q/4qWi9uAp1AithZGREGGo79lhKFDn4G1AnYx
BrBmoJKH22Bm4LXASEhXIodRv3zhixGLpKnPt4+KeHMOYP+6p5MBBnB/YmXBhpJ10YgC/iC8oazP
sN+u78M/xE9kq/+LLp91oxG9/78PipiAEIPg/2WEDrB1o5MBkwCHwXWwDgFvZcGHirXAGlB4hnG8
0WT4cnVtZuC6YYDRdfLKz+/L34qW+KAyQHKnAAkw+3B/BiBAsECQoeGFIJMAo6QoxEVnqCBOT1Mk
8C7wB9CRJPBFMCg2LjEp936gfNLAkGmLsZOBG4DR/+/TD6YZZjBnEHLVgWyhLuD/a3AXQGWEo0Kh
Q2YQbEAGMPuh8WtAZ2tBa0AlILn0pyL/XzBlwNkv2j/bTxuAww/HH//FL+N/5I+be7sR4IDU0tWT
f2WEwVJrQM8TqMLe8bogZv9sUAkw0QLXoKOR3+/g/4qH7+3RQJBsYOtTZ2YQgBAhkf/YCKjEn4EN
8NhhbK/nP+hP9/Jv83/0jEbY8Wtih3F8YP8yoIaj7N/t74qWbEAlIECQ/e+ldmuw37Ko0RtQzuIT
0P/wMIdwiEGDs83F8FG0tDIg+xdAZsBsQIFnACTw2O/6f//uu/4Vk+JmMKDwQLF1wQjg/zIgbAKi
5DITMjB/Uc2RwgL/jwFfMCUwaABmwCSgDhChI/8XTwIPinhnRAlwA/BsEGci/yGgA/A5wAakpyl8
Y+lwM6D+cECg78G5mWaRCB8JL4Ltz82BhfBfMAQhYXd/oX7GfWYQZ2WgZlKPcNTBfcJ3/4PABRAF
4hO2G4AaMA9wqNW3D58Qr4qWdqiSj3BqFfGvdtB2IzIg78EiZ/AtE8b6ZLlwYg9wV/CikVhgC+H/
1VBsj/Yv9z/1Tx3/yB+FEH25QGsWvxfPiocA0TIQcvu0d9VQc3ZgfkGNk39RfPL/g9FsRo6RZxGP
cA9/JG8DG//9EITwHP8hDx8fLN8t7y76/3WAs+FmEHXALK8wvy7PM38bNI81mkIWEOwQTGV3HnIp
cJRQKZ8qoktDTfxPLkr/TAVbPzXfSoRVgQdbAVSPeAFMT0NLUfBVT1RFeD8+j0DvQf8RQw9nNTh3
8k9EWQlADTI3VYFIVE1MFUANMyp1fUrgAAAAHgBCEAEAAAAzAAAAPDkwOTk2QUQ0MEUwNjMxNDNB
NEVGMTc0RDNCN0E1QTBEMTRCM0M1QGxvY2FsaG9zdD4AAAMAAlkAABYAAwAJWQIAAAALAACACCAG
AAAAAADAAAAAAAAARgAAAAADhQAAAAAAAAMABIAIIAYAAAAAAMAAAAAAAABGAAAAAFKFAABzeQEA
HgAFgAggBgAAAAAAwAAAAAAAAEYAAAAAVIUAAAEAAAAEAAAAOS4wAAMABoAIIAYAAAAAAMAAAAAA
AABGAAAAAAGFAAAAAAAACwAPgAggBgAAAAAAwAAAAAAAAEYAAAAADoUAAAAAAAADABCACCAGAAAA
AADAAAAAAAAARgAAAAAQhQAAAAAAAAMAEYAIIAYAAAAAAMAAAAAAAABGAAAAABGFAAAAAAAAAwAU
gAggBgAAAAAAwAAAAAAAAEYAAAAAGIUAAAAAAAALANaACCAGAAAAAADAAAAAAAAARgAAAAAGhQAA
AAAAAB4A14AIIAYAAAAAAMAAAAAAAABGAAAAAIOFAAABAAAAEwAAADAxNTExMjkxNS0xOTAxMjAw
NQAAAgH4DwEAAAAQAAAADXLFVbdB0xGv5QAA9j3ScAIB+g8BAAAAEAAAAA1yxVW3QdMRr+UAAPY9
0nACAfsPAQAAAEoAAAAAAAAAOKG7EAXlEBqhuwgAKypWwgAAbXNwc3QuZGxsAAAAAABOSVRB+b+4
AQCqADfZbgAAAE86XEFcYWhlaWxcYWhlaWwucHN0AAAAAwD+DwUAAAADAA00/TcAAAIBfwABAAAA
MQAAADAwMDAwMDAwMEQ3MkM1NTVCNzQxRDMxMUFGRTUwMDAwRjYzREQyNzAwNDNCM0YwMAAAAAAD
AAYQ4y2E5gMABxBREAAAAwAQEAAAAAADABEQAQAAAB4ACBABAAAAZQAAAFdIQVRJRldFSEFEQUhB
TkRZV0FZVE9SRU5ERVJDT05UUk9MTEVEU1VCU1RBTkNFU05PTlJFQ09WRVJBQkxFP0xFVFNTUEVD
VUxBVEVUSEFUV0VIQURTT01FU09SVE9GU01BTEwAAAAAQP8=

------=_NextPart_000_0007_01C4FDF9.22B9C320--